These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20084616)

  • 1. Injection site-dependent induction of immune response by DNA vaccine: comparison of skin and spleen as a target for vaccination.
    Guan X; Nishikawa M; Takemoto S; Ohno Y; Yata T; Takakura Y
    J Gene Med; 2010 Mar; 12(3):301-9. PubMed ID: 20084616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced CTL response by controlled intracellular trafficking of antigen in dendritic cells following DNA vaccination.
    Isaji K; Kawase A; Matono M; Guan X; Nishikawa M; Takakura Y
    J Control Release; 2009 May; 135(3):227-33. PubMed ID: 19331843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antigen-specific antibody production following polyplex-based DNA vaccination via the intradermal route in mice.
    Kawase A; Isaji K; Yamaoka A; Kobayashi N; Nishikawa M; Takakura Y
    Vaccine; 2006 Jul; 24(27-28):5535-45. PubMed ID: 16716462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a novel Hsp70-based DNA vaccine as a multifunctional antigen delivery system.
    Yamaoka A; Guan X; Takemoto S; Nishikawa M; Takakura Y
    J Control Release; 2010 Mar; 142(3):411-5. PubMed ID: 19913062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early events of electroporation-mediated intramuscular DNA vaccination potentiate Th1-directed immune responses.
    Grønevik E; Mathiesen I; Lømo T
    J Gene Med; 2005 Sep; 7(9):1246-54. PubMed ID: 15822067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice.
    Hattori Y; Kawakami S; Suzuki S; Yamashita F; Hashida M
    Biochem Biophys Res Commun; 2004 May; 317(4):992-9. PubMed ID: 15094367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmid DNA vaccines are effective in the absence of IFNgamma.
    Hassett DE; Zhang J; Whitton JL
    Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.
    Maecker HT; Umetsu DT; DeKruyff RH; Levy S
    J Immunol; 1998 Dec; 161(12):6532-6. PubMed ID: 9862678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of antigen expression from plasmid DNA in tumor-free and antigen-expressing tumor-bearing mice.
    Guan X; Guan X; Nishikawa M; Nishikawa M; Li H; Li H; Rei T; Rei T; Takahashi Y; Takahashi Y; Takakura Y; Takakura Y
    Hum Vaccin Immunother; 2012 Feb; 8(2):194-200. PubMed ID: 22426379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo plasmid electroporation induces tumor antigen-specific CD8+ T-cell responses and delays tumor growth in a syngeneic mouse melanoma model.
    Kalat M; Küpcü Z; Schüller S; Zalusky D; Zehetner M; Paster W; Schweighoffer T
    Cancer Res; 2002 Oct; 62(19):5489-94. PubMed ID: 12359758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration.
    Hattori Y; Kawakami S; Lu Y; Nakamura K; Yamashita F; Hashida M
    J Gene Med; 2006 Jul; 8(7):824-34. PubMed ID: 16625665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of both cellular and humoral responses to genetic immunization by co-administration of an antigen-expressing plasmid and a plasmid encoding the pro-apoptotic protein Bax.
    Kinsey BM; Marcelli M; Song L; Bhogal BS; Ittmann M; Orson FM
    J Gene Med; 2004 Apr; 6(4):445-54. PubMed ID: 15079819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
    J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of anti-tumor immunity by intrasplenic administration of a carcinoembryonic antigen DNA vaccine.
    White SA; LoBuglio AF; Arani RB; Pike MJ; Moore SE; Barlow DL; Conry RM
    J Gene Med; 2000; 2(2):135-40. PubMed ID: 10809147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enhanced translational efficacy of internal ribosomal entry site-mediated mRNA in dendritic cells contributes to efficient induction of antitumor immunity].
    Tan XH; Wan YH
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):399-403. PubMed ID: 17456382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen.
    Bråve A; Hallengärd D; Gudmundsdotter L; Stout R; Walters R; Wahren B; Hallermalm K
    Vaccine; 2009 Jun; 27(28):3692-6. PubMed ID: 19428161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic and therapeutic intervention in IgE responses by biolistic DNA vaccination primarily targeting dendritic cells.
    Sudowe S; Ludwig-Portugall I; Montermann E; Ross R; Reske-Kunz AB
    J Allergy Clin Immunol; 2006 Jan; 117(1):196-203. PubMed ID: 16387606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin-specific promoters for genetic immunisation by DNA electroporation.
    Vandermeulen G; Richiardi H; Escriou V; Ni J; Fournier P; Schirrmacher V; Scherman D; Préat V
    Vaccine; 2009 Jul; 27(32):4272-7. PubMed ID: 19450641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
    Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K
    Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.